# AD_representation
Supplement to Representation and Outcomes of Individuals with Major Depression in Routine Care Who Are Ineligible for Randomized Clinical Trials

Aleksi Hamina1,2,  Justo Pinzón-Espinosa3-6, Heidi Taipale1,7,8, Johannes Schneider-Thoma9,10, Joaquim Radua11-13, Orestis Efthimiou14,15, Narcís Cardoner16-19, Christoph U. Correll20-24, Paolo Fusar-Poli25-28, Ellenor Mittendorfer-Rutz29, Brenda W.J.H. Penninx30, Henricus G. Ruhe31,32, Antti Tanskanen1,7, Christiaan Vinkers3,33-35, Stefan Leucht9,10, Eduard Vieta18,36-38, Andrea Cipriani39-41, Jari Tiihonen1,7,42, Jurjen J. Luykx3,33-35,43: Representation and outcomes of individuals with major depression in routine care who are ineligible for randomized controlled trials: a nationwide register-based study


1 Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland; 2 Norwegian Centre for Addiction Research, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; 3 Department of Psychiatry, Amsterdam University Medical Center, Amsterdam, The Netherlands; 4 Department of Clinical Psychiatry, School of Medicine, University of Panama, Panama City, Panama; 5 Center of Population Sciences for Health Empowerment, Florida State University, Tallahassee, FL, USA; 6 Instituto de Investigaciones Científicas y Servicios de Alta Tecnología, Panama City, Panama; 7 Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; 8 School of Pharmacy, University of Eastern Finland, Kuopio, Finland; 9 Department of Psychiatry and Psychotherapy, School of Medicine and Health, Technical University of Munich, Munich, Germany; 10 German Center for Mental Health, partner site Munich-Augsburg, Germany; 11 Imaging of Mood- and Anxiety-Related Disorders Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer, CIBERSAM, Barcelona, Spain; 12 Centre for Psychiatric Research and Education, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; 13 Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; 14 Institute of Primary Health Care, University of Bern, Bern, Switzerland; 15 Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; 16 Psychiatry Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; 17 Institut d'Investigació Biomèdica Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; 18 Centro de Investigación Biomédica En Red en Salud Mental, Instituto de Salud Carlos III, Madrid, Spain; 19 Department of Psychiatry and Forensic Medicine, School of Medicine Bellaterra, Universitat Autònoma de Barcelona, Barcelona, Spain; 20 Department of Psychiatry, Zucker Hillside Hospital, Glen Oaks, NY, USA; 21 Department of Psychiatry and Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA; 22 Center for Psychiatric Neuroscience, Feinstein Institute for Medical Research, New Hyde Park, NY, USA; 23 Department of Child and Adolescent Psychiatry, Charité - Universitätsmedizin Berlin, Berlin, Germany; 24 German Center for Mental Health, partner site Berlin, Germany; 25 Department of Brain and Behavioral Sciences, University of Pavia, Italy; 26 Early Psychosis: Interventions and Clinical-detection (EPIC) Lab, Department of Psychosis Studies, King’s College London, London, UK; 27 Outreach and Support in South-London (OASIS) Service, South London and Maudlsey NHS Foundation Trust, London, UK; 28 Department of Psychiatry and Psychotherapy, University Hospital, Ludwig-Maximilian-University, Munich, Germany; 29 Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; 30 Department of Psychiatry and Amsterdam Public Health, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands; 31 Department of Psychiatry, Radboudumc, Nijmegen, The Netherlands; 32 Donders Institute for Brain, Cognition and Behavior, Radboud University, Nijmegen, The Netherlands; 33 GGZ inGeest Mental Health Care, Amsterdam, The Netherlands; 34 Amsterdam Neuroscience and Public Health Research Institutes, Amsterdam, The Netherlands; 35 Department of Anatomy and Neurosciences, Amsterdam University Medical Center, Amsterdam, The Netherlands; 36 Departament de Medicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain; 37 Bipolar and Depressive Disorders Unit, Hospital Clinic de Barcelona, Barcelona, Spain; 38 Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; 39 Department of Psychiatry, University of Oxford, Oxford, UK; 40 Oxford Precision Psychiatry Lab, NIHR Oxford Health Biomedical Research Centre, Oxford, UK; 41 Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, UK; 42 Neuroscience Center, University of Helsinki, Helsinki, Finland; 43 Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands
